- About MAB
|Date of Establishment||September 26, 2013|
|Chairman||Toshiaki Higashihara (President & CEO, Hitachi, Ltd.)|
|Associate Members||ABLE Corporation, ALPS ELECTRIC CO., LTD., Asahi Kasei Medical Co., Ltd.,
ASAHI YUKIZAI CORPORATION, Chitose Laboratory Corp., chromocenter Inc.,
DAIICHI SANKYO COMPANY, LIMITED, FUJIMORI KOGYO CO., LTD., GL Sciences Inc.,
Hitachi, Ltd., IS JAPAN Co., Ltd., JNC CORPORATION, JSR Life Sciences Corporation,
KANEKA CORPORATION, Kyoto Monotech Ltd., Mitsubishi Chemical Corporation,
Nippi, Incorporated, Nippon Zenyaku Kogyo Co., Ltd., On-chip Biotechnologies Co., Ltd.,
OSAKA SODA CO., LTD., SHARP LIFE SCIENCE CORPORATION,
SHIMADZU CORPORATION, Sumitomo Bakelite Co., Ltd.,
Sumitomo Electric Industries, Ltd., TOSOH CORPORATION, TOTO LTD.,
Tokyo Chemical Industry Co., Ltd., YMC CO., LTD., Yokogawa Electric Corporation,
Japan Blood Products Organization (General Incorporated Association),
Japan Bioindustry Association (General Incorporated Foundation),
Kihara Memorial Yokohama Foundation for the Advancement of Life Sciences (Public Interest Incorporated Foundation),
National Institute of Advanced Industrial Science and Technology (National Research and Development Agency),
Tokushima University, Kobe University, Kyushu University, Yamaguchi University.
(including: 29 Companies, 3 Organizations, 1 National Research and Development Agency and 4 Universities)
|Project Outline||In FY2013 and FY2014, the project focused on developing key technologies for discovering and manufacturing pharmaceuticals used for next-generation treatments and diagnoses
[sponsored by the Ministry of Economy, Trade and Industry (METI), Japan].
In FY2015, FY2016 and FY2017, the project focused on developing key technologies for discovering and manufacturing pharmaceuticals used for next-generation treatments and diagnoses
[sponsored by the Japan Agency for Medical Research and Developmet (AMED)].
|Kobe GMP Facilities||